Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Morgan Stanley (MS)

Morgan Stanley (MS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?

Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. Valued at $17.9 billion by market cap, the company’s technologies include the design and manufacture of packaging components, research and development of drug delivery systems, and contract laboratory services and other services.

Shares of this leading manufacturer of containment and delivery systems have outperformed the broader market over the past year. WST has gained 20.4% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 11.7%. However, in 2026, WST’s stock fell 11.4%, compared to...

Fundamentals

See More
  • Market Capitalization, $K 277,127,808
  • Shares Outstanding, K 1,589,309
  • Annual Sales, $ 70,645 M
  • Annual Income, $ 16,861 M
  • EBIT $ 21,954 M
  • EBITDA $ 27,115 M
  • 60-Month Beta 1.20
  • Price/Sales 2.35
  • Price/Cash Flow 15.34
  • Price/Book 2.78

Options Overview Details

View History
  • Implied Volatility 32.34% (-2.08%)
  • Historical Volatility 32.29%
  • IV Percentile 81%
  • IV Rank 21.85%
  • IV High 71.89% on 04/08/25
  • IV Low 21.28% on 08/26/25
  • Expected Move (DTE 7) 5.30 (3.02%)
  • Put/Call Vol Ratio 1.73
  • Today's Volume 22,332
  • Volume Avg (30-Day) 18,729
  • Put/Call OI Ratio 1.46
  • Today's Open Interest 390,801
  • Open Int (30-Day) 346,630
  • Expected Range 170.11 to 180.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.89
  • Number of Estimates 7
  • High Estimate 3.17
  • Low Estimate 2.52
  • Prior Year 2.60
  • Growth Rate Est. (year over year) +11.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.59 +7.23%
on 02/13/26
188.68 -7.03%
on 02/03/26
-6.69 (-3.67%)
since 01/20/26
3-Month
155.23 +13.00%
on 11/21/25
192.68 -8.96%
on 01/16/26
+16.71 (+10.53%)
since 11/20/25
52-Week
94.33 +85.95%
on 04/07/25
192.68 -8.96%
on 01/16/26
+41.07 (+30.57%)
since 02/20/25

Most Recent Stories

More News
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?

West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

$SPX : 6,909.51 (+0.69%)
MS : 175.41 (+0.60%)
WST : 241.12 (-1.11%)
MDEV : 20.69 (+0.41%)
Morgan Stanley Schedules Fourth Quarter and Full-Year 2026 Investor Conference Call

Morgan Stanley (NYSE: MS) will announce its fourth quarter and full-year 2026 financial results on Thursday, January 14, 2027, at approximately 7:30 a.m. (ET). A conference call to discuss the results...

MS : 175.41 (+0.60%)
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows

Get context for CRISPR Therapeutics’ Q4 results: CASGEVY launch economics, cash runway, pipeline upside, and the technical level investors should watch.

CRSP : 53.46 (-2.16%)
MS : 175.41 (+0.60%)
VRTX : 476.90 (+1.63%)
Morgan Stanley Wealth Management Reduces Fees on Private Shares Marketplace EquityZen, Broadening Private Markets Access

Buy and Sell Side Fees Reduced to 2.5% for Investors and Shareholders

MS : 175.41 (+0.60%)
1 S&P 500 Stock on Our Buy List and 2 We Ignore

1 S&P 500 Stock on Our Buy List and 2 We Ignore

JKHY : 159.19 (-1.21%)
MS : 175.41 (+0.60%)
WAT : 333.33 (+1.42%)
ResMed Stock Outlook: Is Wall Street Bullish or Bearish?

As ResMed has outpaced the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

$SPX : 6,909.51 (+0.69%)
MS : 175.41 (+0.60%)
RMD : 259.12 (+1.10%)
IHI : 59.36 (+0.41%)
Are Wall Street Analysts Predicting Equinix Stock Will Climb or Sink?

Equinix has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 6,909.51 (+0.69%)
MS : 175.41 (+0.60%)
EQIX : 928.11 (+1.10%)
SRVR : 33.09 (+0.88%)
Tony Clark resigns as MLB players' union head as possible cap fight looms

Tony Clark has resigned as head of the Major League Baseball Players Association, the union announced said, as a possible salary cap fight looms during a federal investigation of its finances

MS : 175.41 (+0.60%)
US stocks edge higher after swinging through worries about AI and the economy

A quiet finish for U.S. stocks masked big swings underneath the surface

NFLX : 78.67 (+2.17%)
META : 655.66 (+1.69%)
GOOGL : 314.98 (+4.01%)
NVDA : 189.82 (+1.02%)
AAPL : 264.58 (+1.54%)
BAC : 53.06 (+0.55%)
$SPX : 6,909.51 (+0.69%)
MS : 175.41 (+0.60%)
$IUXX : 25,012.62 (+0.87%)
GIS : 44.62 (-0.40%)
MSFT : 397.23 (-0.31%)
TSLA : 411.82 (+0.03%)
Morgan Stanley Investment Management Closes Revolving and Rated Private Securitization Backed by Consumer Loans

Approximately $220 million total loan purchase capacity estimated

MS : 175.41 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Morgan Stanley, being the leading financial services holding company, serves corporations, governments, FIs & individuals world wide. It has 3 business units. The Institutional Securities unit includes capital raising, financial advisory services on mergers & acquisitions, restructurings, real estate...

See More

Key Turning Points

3rd Resistance Point 180.58
2nd Resistance Point 178.01
1st Resistance Point 176.71
Last Price 175.41
1st Support Level 172.83
2nd Support Level 170.26
3rd Support Level 168.96

See More

52-Week High 192.68
Last Price 175.41
Fibonacci 61.8% 155.11
Fibonacci 50% 143.51
Fibonacci 38.2% 131.90
52-Week Low 94.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar